Edmonton, Canada

Inderjit S Sidhu


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inderjit S Sidhu: Innovator in Quinazoline Compounds**

Introduction

Inderjit S Sidhu, based in Edmonton, CA, is a noteworthy inventor known for his significant contribution to the field of pharmaceuticals. With a focus on developing innovative compounds, Sidhu has made strides in treating various cell proliferative diseases and disorders.

Latest Patents

Sidhu holds a patent for "Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes." This invention revolves around a group of 2-arylamino-7-(alkyl)oxy-8-alkylquinazolines and 8-alkyl-2-arylamino-quinazoline 2,7-diamines, which serve as potent inhibitors of cyclin-dependent kinases (cdks). These compounds have displayed promise in treating a wide array of health issues, including cardiovascular diseases, infections, cancers, autoimmune diseases, gout, kidney disease, and neurodegenerative disorders like Alzheimer's disease. The compounds can be synthesized easily, administered through various routes, including orally, and demonstrate favorable bioavailability. Furthermore, Sidhu's invention includes pharmaceutical formulations that comprise these quinazoline compounds along with acceptable carriers or excipients.

Career Highlights

Inderjit S Sidhu has developed his expertise while working at Warner-Lambert Company, where he has been able to apply his knowledge and skills in the realm of drug development. His patent, along with its applications, highlights Sidhu's pivotal role in enhancing treatment options for serious health conditions.

Collaborations

Throughout his career, Sidhu has collaborated with notable coworkers, including Mark Robert Barvian and Ellen Myra Dobrusin. These partnerships have further empowered Sidhu’s capacity to innovate and develop cutting-edge therapeutic solutions.

Conclusion

Inderjit S Sidhu is an influential figure in the world of pharmaceuticals, and his innovative work in quinazoline compounds is a testament to his commitment to improving human health. With a patent that has substantial implications for treating a variety of serious diseases, Sidhu represents the spirit of innovation that drives advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…